
Cardiome Pharmas commercial sale and distributors agreement with Algorithm for the BRINAVESS drug is for a period of five years. (Image source: Wolfman.K/Flickr)
US-based Cardiome Pharma has named Lebanons Algorithm as the exclusive seller and distributor for its intravenous investigational drug BRINAVESS, in certain parts of North Africa and the Middle East